Caspofungin acetate
Key facts
Invented name |
|
Active substance |
caspofungin acetate
|
Therapeutic area |
Infectious diseases
|
Decision number |
P/30/2008
|
PIP number |
Caspofungin acetate
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Fungal infections
|
Route(s) of administration |
Intravenous use
|
Contact for public enquiries |
Merck Sharp & Dohme (Europe) Ltd
|
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-C-000010-PIP01-07-M01
|
Compliance opinion date |
04/06/2008
|
Compliance outcome |
positive
|